NCT05303870

Brief Summary

Prevalence of anxiety and depression in the general population is known, but is under researched in the acute hospital setting and there is little evidence on the prevalence of anxiety and depression within the emergency medical admission population. A potential intervention for treating such mental health prevalence would be in the form of IAPT methodology which has been utilised in other parts of the NHS demonstrating good outcomes. Therefore, this feasibility study will explore the utility of IAPT in the acute setting. This study will explore the prevalence of anxiety and depression in the emergency medical population within medical inpatient wards , utilising the assessment tools adopted by the IAPT services and explained in detail below. The study will explore a) feasibility of introducing psychological intervention to an emergency medical ward and b) provide preliminary data on the outcome of this intervention on hospital length of stay and readmission rates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 21, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 27, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 27, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
Last Updated

July 27, 2022

Status Verified

July 1, 2022

Enrollment Period

6 months

First QC Date

February 21, 2022

Last Update Submit

July 26, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants with moderate or severe anxiety

    How many participants enrol in to the study, that are eligible to participate.

    Up to 6 months

Secondary Outcomes (1)

  • IAPT views

    Up to 6 months

Study Arms (1)

IAPT

EXPERIMENTAL
Other: Improving access to psychological therapies (IAPT)

Interventions

IAPT services provide evidence-based treatments for people with depression and anxiety disorders, and comorbid long-term physical health conditions or medically unexplained symptoms. IAPT services are characterised by three key principles: 1. Evidence-Based psychological therapies at the appropriate dose: NICE recommended therapies matched to the mental health problem, at the intensity and duration designed to optimise outcomes. 2. Appropriately trained and supervised workforce. 3. Routine outcome monitoring.

IAPT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted to Ipswich Hospital into a ward that cares for patients who are medical emergencies.
  • Patients who score 3 or higher on one or both of the GAD 2 and PHQ 2.
  • Patients that have capacity to consent.
  • Over 18 years old.
  • Ability to speak and read in English as the study will not have the resources to employ interpreters or to get documentation translated.
  • Participants that are not deemed suicidal via screening and medical and nurse assessment.

You may not qualify if:

  • Patients not receiving care on a ward caring for medical emergencies.
  • Patients under the age of 18 years old.
  • Patients scoring \< 3 on both GAD 2 and PHQ 2.
  • Patients who do not have capacity to consent.
  • Participants that are suicidal as via screening and medical and nurse assessment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

East Suffolk and North Essex NHS Foundation Trust

Ipswich, IP4 5PD, United Kingdom

Location

MeSH Terms

Conditions

Mental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2022

First Posted

March 31, 2022

Study Start

October 10, 2021

Primary Completion

March 27, 2022

Study Completion

March 27, 2022

Last Updated

July 27, 2022

Record last verified: 2022-07

Locations